Schizophrenia and schizoaffective disorders are severe mental conditions characterized by hallucinations, delusions, and mood disturbances. The Journal of Clinical Psychiatry offers a deep dive into these disorders, emphasizing their diagnosis, management, and underlying causes. Our expert editors ensure content is both clinically relevant and actionable, aiding psychiatrists in offering effective and compassionate care.
Schizophrenia and Schizoaffective Disorders
Page 13
Recently published articles about Schizophrenia/Schizoaffective Disorders
Original Research
Add-on Pramipexole for Schizophrenia
August 1, 2022
Several small clinical trials have reported that the dopamine agonist pramipexole was beneficial in treating patients with schizophrenia. This 16-week, multicenter, double-blind, randomized, placebo-controlled study was conducted to test...
Original Research
Effects of a Digital Medicine System on Psychiatric Hospitalization Rates for Adults With Schizophrenia
April 11, 2022
This clinical trial investigated whether hospitalization rates improved when patients with schizophrenia were treated via a digital medicine system (aripiprazole tablets with sensor) versus oral standard-of-care therapy.
Original Research
Differences Among Second-Generation Antipsychotics in Effects on HbA1c
March 30, 2022
The antipsychotic blonanserin was associated with less change in glycated hemoglobin (HbA1c) levels than olanzapine, and changes in BMI were lower for both blonanserin and aripiprazole. Study results indicate...
